Ethical considerations
The study, including the extension-study, was approved by the Swedish Ethical Review Board and the Swedish Medical Products Agency (no. 2021-06046-02 and no. 5.1-2021-92151, respectively). Informed consent was obtained from all study participants prior to inclusion in the study.